课题基金 / 基金详情

Identification of Gab1 as a novel therapeutic target for hepatocellular carcinoma

Identification of Gab1 as a novel therapeutic target for hepatocellular carcinoma
Gab1作为肝细胞癌新治疗靶点的鉴定
批准号:
23590974
负责人:
YOSHIDA YUICHI
金额:
$3.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

YOSHIDA YUICHI的其他基金

相似基金

相关文献

中文摘要
翻译
近年来,对肝细胞癌的分子发病机制,包括生长因子或受体酪氨酸激酶(RTKs)信号通路有了更深入的了解,从而导致了新型分子靶向治疗的发展。Grb2相关的结合子GAB1是一种支架对接适配器,可以放大广泛的生长因子/受体酪氨酸激酶下游的信号,例如HGF/c-MET-或HB-EGF/EGFR-信号通路。尽管这些信号与肝癌的发生有关,但GAB1的作用仍不清楚。在这里,我们研究了GAB1在肝癌中的作用,并证明了GAB1在体内外调节肝癌细胞的增殖。此外,小鼠肝细胞特异性GAB1基因的缺失导致了肝纤维化的增强,这是人类肝癌的主要原因。综上所述,我们目前的结果表明GAB1在肝癌的发生中起着重要的作用,并且GAB1可能成为肝癌的一个新的分子靶点。
英文摘要
Recently, a better understanding of molecular pathogenesis regarding hepatocellular carcinoma (HCC), including growth factor or receptor Tyrosine Kinases (RTKs) signaling, has led to the development of the novel molecular target therapy. Grb2-associated binder Gab1 is a scaffolding docking adaptor that amplifies signals downstream of a broad range of growth factors/receptor tyrosine kinases, such as HGF/c-MET- or HB-EGF/EGFR- signaling pathways. Although these signals are implicated in liver carcinogenesis, the roles of Gab1 remain unclear. Here, we investigated the role of Gab1 in HCC and demonstrated that Gab1 regulates the proliferation of HCC cells in vitro and in vivo. Furthermore, hepatocyte-specific deletion of Gab1 in mice resulted in the enhanced liver fibrosis, which is the major cause of HCC in human. Together, our current results indicate the crucial role of Gab1 in hepatocarcinogenesis and that Gab1 could be a novel molecular target for HCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
急性肝不全における肝細胞アダプター蛋白質Gab1の役割
肝细胞衔接蛋白Gab1在急性肝衰竭中的作用
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [古田訓丸, 吉田雄一, 木津崇, 柄川真弓, 茶谷徳啓, 濱野美奈, 江崎久男, 鎌田佳宏, 木曽真一, 竹原徹郎]
通讯作者: 竹原徹郎
Crucial role of FoxM1 transcription factor as a predictor of clinical outcomes in patients with hepatocellular carcinoma
FoxM1转录因子作为肝细胞癌患者临床结果预测因子的关键作用
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Mayumi Egawa, Yuichi Yoshida, Shinichi Kiso, Akira Tomokuni, Takashi Kizu, Kunimaro Furuta, Takayo Takemura, Mina Hamano, Norihiro Chatani, Hisao Ezaki, Yoshihiro Kamada, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, and Tetsuo Takehara]
通讯作者: and Tetsuo Takehara
Association of lipid overaccumulation with delayed liver regeneration in mice with simple steatosis
单纯性脂肪变性小鼠脂质过度积累与肝再生延迟的关系
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Mina Hamano, Hisao Ezaki, Kunimaro Furuta, Mayumi Egawa, Takashi Kizu, Norihiro Chatani, Yoshihiro Kamada, Yuichi Yoshida, Shinichi Kiso, Tetsuo Takehara]
通讯作者: Tetsuo Takehara
共 38 条
    The role of FoxM1 transcription factor in the development of hepatic inflammation, liver fibrosis, and hepatocellular carcinoma: the study using conditional transgenic mice
    • 批准号:
      26461001
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      YOSHIDA YUICHI
    • 依托单位:
    海外基金